Building an Infectious Disease Diversity, Equity, and Antiracism (ID2EA) Curriculum: A Single Center's Experience and Reflections.

In response to longstanding healthcare inequities unmasked by the Coronavirus Disease 2019 pandemic, the infectious diseases (ID) section at the Yale School of Medicine designed and implemented a pilot curriculum integrating Infectious Disease Diversity, Equity, and Antiracism (ID2EA) into ID educational training and measured program outcomes. We herein describe a mixed-methods assessment of section members on whether the ID2EA curriculum affected their beliefs and behaviors regarding racism and healthcare inequities. Participants rated the curriculum as useful (92% averaging across sessions) and effective in achieving stated learning objectives (89% averaging across sessions), including fostering understanding of how inequities and racism are linked to health disparities and identifying strategies to effectively deal with racism and inequities. Despite limitations in response rates and assessment of longer-term behavioral change, this work demonstrates that training in diversity, equity, and antiracism can be successfully integrated into ID physicians' educational activities and affect physicians' perspectives on these topics.

"Why did they die?": biomedical narratives of epidemics and mortality among amazonian indigenous populations in sociohistorical and anthropological contexts

Texto multi e interdisciplinar, que resulta de mais de 10 anos de uma pesquisa colaborativa conduzida por Ricardo Ventura Santos (ENSP/Fiocruz e Museu Nacional/ UFRJ), Carlos Coimbra Jr. (ENSP) e Joanna Radian (Yale University). Santos e Coimbra são investigadores ligados ao Grupo de Pesquisa sobre Saúde dos Povos Indígenas da ENSP/Fiocruz e ao Grupo de Trabalho sobre Saúde Indígena da Associação Brasileira de Saúde Coletiva (Abrasco). Abordando desde os primórdios dos testes da vacina contra o sarampo nos anos 1960, o trabalho analisa e contextualiza narrativas da biomedicina sobre a vulnerabilidade dos povos indígenas frente às doenças infecciosas ao longo de meio século.

Unfolding epidemiological stories: how the WHO made frozen blood into a flexible resource for the future.

In the decades after World War II, the World Health Organization (WHO) played an important role in managing the process of stabilizing collections of variable blood samples as a fundamentally unstable, protean, and unfolding biomedical resource. In this system, known and as yet unknown constituents of blood were positioned as relevant to the work of multiple constituencies including human population geneticists, physical anthropologists, and immunologists. To facilitate serving these and other constituencies, it was crucial to standardize practices of collecting and preserving samples of blood from globally distributed human populations. The WHO achieved this by linking its administrative infrastructure-comprised of expert advisory groups and technical reports-to key laboratories, which served as sites for demonstrating and also for disseminating standards for working with variable blood samples. The practices that were articulated in making blood samples into a flexible resource contributes to emerging histories of global health that highlight the centrality of new institutions, like the WHO, new forms of expertise, like population genetics and serological epidemiology, and new kinds of research materials, like frozen blood.